More about

Ckd-Related Anemia

News
December 06, 2024
2 min read
Save

Oral vadadustat noninferior to erythropoiesis-stimulating therapy for CKD-related anemia

Oral vadadustat three times per week was noninferior to a long-acting erythropoiesis-stimulating agent for treating anemia in patients with chronic kidney disease on dialysis, according to study data.